Breaking News

Jubilant HollisterStier Enters $149.6M Agreement with U.S. Govt.

To double injectable filling production capacity at a total cost of $193 million, at its Spokane, WA manufacturing facility.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jubilant Pharmova Ltd. through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a US-based pharmaceutical contract manufacturer has entered into a $149.6 million cooperative agreement with the Army Contracting Command, in coordination with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) on behalf of the Biomedical Advanced Research and Development Authority (BARDA), within the US Department of Health and Human Se...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters